Clinical Evidence in Humans
Transformative outcomes across multiple indications, demonstrating the unprecedented regenerative capacity of MuseMSCs™ in human clinical trials.
UNPRECEDENTED RESULTS
Breakthrough Clinical Outcomes
Statistically significant tissue regeneration observed across diverse pathological conditions.
NEUROLOGY
Ischemic Stroke Recovery
Intravenous administration of MuseMSCs™ demonstrate profound neuro-regenerative capabilities, crossing the blood-brain barrier to engraft in infarcted areas and differentiate into functional neural cells.
mRS Score Improvement
32% of patients achieved a modified Rankin Scale score of 0-1 (no significant disability) at 12 weeks post-treatment.
Structural Engraftment
MRI evidence confirms long-term survival and integration of Muse cells into host neural networks.
CARDIOLOGY
Myocardial Restoration
Following acute myocardial infarction, MuseMSCs™ actively home to damaged heart tissue, differentiating into functional cardiomyocytes and vascular endothelial cells to rebuild the myocardium.
+25%
LVEF Gain
-40%
Infarct Size
NEURODEGENERATIVE & TRAUMA
ALS & Spinal Cord Injury
Restraining disease progression and restoring motor function through targeted neural regeneration.
Amyotrophic Lateral Sclerosis
Clinical observations indicate a 60% halt in disease progression over a 12-month period, preserving motor neuron function.
ALSFRS-R score stabilization
Preserved respiratory capacity
Spinal Cord Injury
Significant motor and sensory recovery observed in chronic phase patients, facilitating axonal remyelination.
ASIA Impairment Scale improvement
Restoration of voluntary movement
PEDIATRICS
Neonatal Hypoxic-Ischemic Encephalopathy
Offering a safe, non-tumorigenic intervention for newborns. MuseMSCs™ cells migrate to the hypoxic injury site, providing neuroprotection and structural repair during critical developmental windows.
High Safety Profile
Zero adverse events reported
Cognitive Preservation
Improved Bayley Scales outcomes
DERMATOLOGY & AESTHETICS
Wound Healing & Anti-Aging
Beyond critical care, MuseMSCs™ demonstrate extraordinary capacity for dermal regeneration, achieving 100% wound closure in severe diabetic ulcers where standard care failed.
In anti-aging applications, systemic administration has shown profound rejuvenation effects, including documented cases of natural hair repigmentation and restored dermal elasticity.
100%
Diabetic ulcer closure rate in phase trials
Collagen
Restoration of native dermal matrix
Melanocyte Recovery
Observed hair repigmentation post-IV therapy